Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma.

Djukanović R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, Howarth PH, Holgate ST.

Am Rev Respir Dis. 1992 Mar;145(3):669-74.

PMID:
1546849
2.

Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma.

Hoshino M, Nakamura Y, Sim JJ, Yamashiro Y, Uchida K, Hosaka K, Isogai S.

Clin Exp Allergy. 1998 May;28(5):568-77.

PMID:
9645593
3.

Effect of inhaled fluticasone with and without salmeterol on airway inflammation in asthma.

Wallin A, Sue-Chu M, Bjermer L, Ward J, Sandström T, Lindberg A, Lundbäck B, Djukanović R, Holgate S, Wilson S.

J Allergy Clin Immunol. 2003 Jul;112(1):72-8.

PMID:
12847482
4.

The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation.

Djukanović R, Homeyard S, Gratziou C, Madden J, Walls A, Montefort S, Peroni D, Polosa R, Holgate S, Howarth P.

Am J Respir Crit Care Med. 1997 Mar;155(3):826-32.

PMID:
9117012
5.

Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma.

Booth H, Richmond I, Ward C, Gardiner PV, Harkawat R, Walters EH.

Am J Respir Crit Care Med. 1995 Jul;152(1):45-52.

PMID:
7599861
6.

Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids.

Boulet LP, Turcotte H, Laviolette M, Naud F, Bernier MC, Martel S, Chakir J.

Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1308-13.

PMID:
11029336
7.

Airway mast cells and eosinophils correlate with clinical severity and airway hyperresponsiveness in corticosteroid-treated asthma.

Gibson PG, Saltos N, Borgas T.

J Allergy Clin Immunol. 2000 Apr;105(4):752-9. Erratum in: J Allergy Clin Immunol 2001 Feb;107(2):223.

PMID:
10756226
9.
10.

Alterations in airway inflammation and lung function during corticosteroid therapy for atopic asthma.

Faul JL, Demers EA, Burke CM, Poulter LW.

Chest. 2002 May;121(5):1414-20.

PMID:
12006422
11.

Influence of natural antigenic exposure on expiratory flows, methacholine responsiveness, and airway inflammation in mild allergic asthma.

Boulet LP, Turcotte H, Boutet M, Montminy L, Laviolette M.

J Allergy Clin Immunol. 1993 Apr;91(4):883-93.

PMID:
8473677
13.

Regular albuterol, nedocromil sodium, and bronchial inflammation in asthma.

Manolitsas ND, Wang J, Devalia JL, Trigg CJ, McAulay AE, Davies RJ.

Am J Respir Crit Care Med. 1995 Jun;151(6):1925-30.

PMID:
7767541
14.
15.

Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma.

Lim S, Jatakanon A, John M, Gilbey T, O'connor BJ, Chung KF, Barnes PJ.

Am J Respir Crit Care Med. 1999 Jan;159(1):22-30.

PMID:
9872813
16.

Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry.

Djukanović R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, Howarth PH, Holgate ST.

Am Rev Respir Dis. 1990 Oct;142(4):863-71.

PMID:
2221594
17.

Inhaled corticosteroids decrease vascularity of the bronchial mucosa in patients with asthma.

Hoshino M, Takahashi M, Takai Y, Sim J, Aoike N.

Clin Exp Allergy. 2001 May;31(5):722-30.

PMID:
11422131
18.

Effects of ketotifen on symptoms and on bronchial mucosa in patients with atopic asthma.

Hoshino M, Nakamura Y, Shin Z, Fukushima Y.

Allergy. 1997 Aug;52(8):814-20.

19.

Persistent airway T-lymphocyte activation in chronic corticosteroid-treated symptomatic asthma.

Redington AE, Wilson JW, Walls AF, Madden J, Djukanovic R, Holgate ST, Howarth PH.

Ann Allergy Asthma Immunol. 2000 Dec;85(6 Pt 1):501-7.

PMID:
11152173
20.
Items per page

Supplemental Content

Write to the Help Desk